12:52pm Thursday 19 October 2017

Findings of ARB drug study are inconclusive

Scientist with tube

However, we say the findings, published in the Lancet, are inconclusive and if you are taking Angiotensin-receptor blockers (ARBs) you shouldn’t stop based on these findings alone.

Our senior cardiac nurse, Judy O’Sullivan, said:

“This analysis of previous research is inconclusive and anyone taking ARBs to treat their heart disease, or risk of developing it, shouldn’t stop based on this alone.

“The benefits of taking the drug are well established and it remains an effective treatment for many of the 2.6 million people in the UK living with coronary heart disease.

 

“We need more research to look specifically into any potential risks of developing cancer when taking ARBs. For now, anyone concerned about their risk of developing cancer should talk to their doctor.”

We have lots of information about different medicines for your heart and how they may affect you.


Got any questions about this page?

Contact press office


Share on:
or:

MORE FROM Cancers

Health news